Point-of-Care Glucose Testing Market Size & Growth Forecast 2027–2036, By Segments (Product Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Point-of-Care Glucose Testing Market size was worth USD 3.82 Billion in 2026 and is poised to grow at 5.08% CAGR between 2027 and 2036, attaining USD 6.27 Billion by 2036. The industry revenue for 2027 is assessed at USD 3.98 Billion.
Get more details on this report
Request Free Sample ReportPoint-of-Care Glucose Testing Market Intelligence Snapshot
Regional Market Dynamics
- North America benefits from mature healthcare systems, established diabetes management programs, widespread point-of-care adoption, and integration of glucose testing into routine patient care.
- Asia Pacific is expanding rapidly through improving healthcare accessibility, primary care networks, medical technology availability, investment, and rising demand for convenient glucose monitoring.
Segment Momentum
- Home care settings accounted for 41.26% of the market in 2026, supported by growing self-monitoring, user-friendly devices, and increasing preference for convenient diabetes management outside healthcare facilities.
- Test strips are the fastest-growing product type, holding a 47.81% share in 2026, as recurring glucose monitoring, broad meter compatibility, and improved testing convenience continue to drive demand.
Market Expansion Drivers
- Rising diabetes prevalence driving widespread adoption of glucose monitoring devices
- Growing geriatric population increasing demand for continuous and portable glucose monitoring
- Advancements in wearable biosensors improving real-time glucose tracking accuracy
Leading Market Participants
- Leading players in the point-of-care glucose testing market include Abbott Laboratories (United States), Roche Holding AG (Switzerland), Dexcom, Inc. (United States), Medtronic plc (Ireland), Sinocare Inc. (China), ARKRAY, Inc. (Japan), Nova Biomedical Corporation (United States), B. Braun Melsungen AG (Germany), Sanofi S.A. (France), Terumo Corporation (Japan)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.82 Billion
- 2027 Estimated Market Size: USD 3.98 Billion
- Projected Market Size: USD 6.27 Billion by 2036
- Growth Forecast: 5.08% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Test Strips (Product Type) | Home Care Settings (End-use)
- Emerging Opportunity Segment: Test Strips (Product Type) | Home Care Settings (End-use)
Market Growth Drivers and Industry Trends
Rising diabetes prevalence driving widespread adoption of glucose monitoring devices
The increasing burden of diabetes across both developed and emerging economies is creating sustained demand for rapid and accessible blood glucose assessment, which will drive the point-of-care glucose testing market growth. As healthcare providers emphasize timely diagnosis and ongoing glycemic control, point-of-care testing devices are becoming integral to hospitals, clinics, pharmacies, and home healthcare settings. Their ability to deliver immediate results supports faster clinical decision-making, improves treatment adjustments, and enables more frequent monitoring for individuals managing both newly diagnosed and long-term diabetes.
Growing geriatric population increasing demand for continuous and portable glucose monitoring
An expanding elderly population is contributing to higher incidences of diabetes and related metabolic disorders, increasing the need for convenient monitoring solutions. The point-of-care glucose testing market benefits from stronger adoption of portable and user-friendly glucose testing technologies that help older adults monitor blood sugar levels with minimal complexity. Healthcare systems are also encouraging decentralized disease management for aging populations, making compact testing devices valuable for routine monitoring in home care, assisted living facilities, and outpatient environments where regular glucose assessment is essential.
Advancements in wearable biosensors improving real-time glucose tracking accuracy
Continuous innovation in wearable sensing technologies is enhancing the reliability, comfort, and usability of glucose monitoring systems for individuals requiring frequent measurements. These technological developments will propel the point-of-care glucose testing market growth by enabling more accurate real-time glucose tracking with reduced user intervention. Improvements in biosensor sensitivity, data connectivity, and integration with digital health platforms allow healthcare professionals and patients to monitor glucose trends more effectively while supporting personalized disease management through continuous physiological insights.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising diabetes prevalence driving widespread adoption of glucose monitoring devices | 2.2% | High | North America, Asia Pacific | High | Near Term |
| Growing geriatric population increasing demand for continuous and portable glucose monitoring | 1.8% | Moderate | Europe, North America | High | Mid Term |
| Advancements in wearable biosensors improving real-time glucose tracking accuracy | 1.6% | Moderate | North America, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the point-of-care glucose testing market, North America accounted for the largest share in 2026, supported by mature healthcare systems, widespread diabetes management programs, and strong adoption of convenient diagnostic technologies. The region's established network of hospitals, clinics, pharmacies, and other healthcare settings facilitates the use of point-of-care glucose testing for rapid monitoring and treatment decisions. Growing emphasis on preventive healthcare and continuous disease management also encourages the adoption of easy-to-use glucose testing solutions. In addition, technological advancements in portable diagnostic devices and greater integration of testing into routine patient care are strengthening demand across the region.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to experience the fastest growth as healthcare infrastructure expands and awareness of diabetes screening and monitoring increases. Rising healthcare accessibility across developing economies is enabling broader use of point-of-care diagnostic technologies outside major hospitals, while expanding primary care networks are creating additional testing opportunities. Increasing patient demand for convenient and rapid glucose monitoring is also encouraging healthcare providers to adopt decentralized testing approaches. Improvements in medical technology availability, greater healthcare investment, and a growing focus on early detection and long-term disease management are expected to support sustained market growth in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Connected Diabetes MonitoringThe U.S. point-of-care glucose testing market is emphasizing rapid testing solutions that integrate with digital health platforms and clinical workflows. Healthcare providers are expanding access to convenient glucose monitoring across hospitals, outpatient settings, and home-based care.
Germany 🇩🇪
Clinical Accuracy FocusGermany prioritizes point-of-care glucose testing systems that deliver dependable accuracy and efficient use across hospitals and primary care settings. Healthcare providers are adopting devices that support standardized diabetes management and streamlined patient monitoring practices.
Japan 🇯🇵
Aging Care SupportJapan is expanding point-of-care glucose testing to address routine diabetes management within an aging population and community healthcare settings. Device manufacturers are focusing on ease of use, compact designs, and reliable performance for frequent patient monitoring.
South Korea 🇰🇷
Digital Care IntegrationSouth Korea is incorporating point-of-care glucose testing into digitally enabled healthcare services and chronic disease management programs. Healthcare organizations are seeking connected devices that simplify monitoring while improving accessibility for patients and clinicians.
France 🇫🇷
Community Healthcare AccessFrance is strengthening point-of-care glucose testing across community healthcare environments where timely diabetes assessment supports patient care. Providers are emphasizing portable systems that improve testing convenience while maintaining dependable clinical performance.
Italy 🇮🇹
Primary Care DiagnosticsItaly is increasing the use of point-of-care glucose testing within primary care and outpatient settings to support efficient diabetes management. Healthcare professionals are adopting user-friendly testing systems that facilitate rapid clinical decisions and routine patient follow-up.
Segment Leadership and Growth Trends
Point-of-Care Glucose Testing Market Share (%), Product Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Test Strips (Largest & Fastest-Growing Segment)
The test strips segment dominated the point-of-care glucose testing market with a 47.81% share in 2026 while also maintaining the fastest growth. Their leadership is supported by the recurring need for glucose monitoring, compatibility with a wide range of blood-glucose meters, and ease of use in both clinical and home settings. Continuous improvements in testing accuracy, user convenience, and accessibility have further strengthened demand for test strips as an essential component of routine blood glucose monitoring.
End-use Segment Analysis: Home Care Settings (Largest & Fastest-Growing Segment)
The point-of-care glucose testing market was led by the home care settings segment, which accounted for a 41.26% share in 2026 and also emerged as the fastest-growing end-use category. The growing prevalence of diabetes, increasing emphasis on self-monitoring, and rising preference for convenient disease management outside traditional healthcare facilities have significantly expanded home-based glucose testing. Greater availability of user-friendly monitoring devices, improved patient awareness, and the shift toward personalized chronic disease management continue to reinforce the strong adoption of point-of-care glucose testing in home care settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Lancing Devices, Test Strips, Blood-glucose Meter | Test Strips | Test Strips |
| End-use | Hospitals, Clinics, Diagnostic Centers, Home Care Settings, Others | Home Care Settings | Home Care Settings |
Competitive Landscape and Market Positioning
Prominent players in the point-of-care glucose testing market:
- Abbott Laboratories (United States)
- Roche Holding AG (Switzerland)
- Dexcom, Inc. (United States)
- Medtronic plc (Ireland)
- Sinocare, Inc. (China)
- ARKRAY, Inc. (Japan)
- Nova Biomedical Corporation (United States)
- B. Braun Melsungen AG (Germany)
- Sanofi S.A. (France)
- Terumo Corporation (Japan)
The point-of-care glucose testing market is evolving as healthcare providers and patients increasingly expect testing systems that combine speed, accuracy, and seamless digital integration. Manufacturers are differentiating through user-friendly device design, enhanced measurement reliability, and connectivity features that support continuous data sharing within broader diabetes management workflows. Competitive pressure is also expanding beyond clinical settings as home-based monitoring becomes a more integral component of long-term care, encouraging suppliers to balance convenience with dependable analytical performance. Businesses that successfully integrate intuitive operation, regulatory compliance, and secure data management are strengthening their position as glucose monitoring becomes more closely connected with personalized healthcare delivery.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Point-of-Care Glucose Testing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Point-of-Care Glucose Testing Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow large is the point-of-care glucose testing market?
How is the point-of-care glucose testing industry expected to grow over the next 10 years?
What factors are accelerating adoption of point-of-care glucose testing technologies?
How are wearable technologies influencing the point-of-care glucose testing market?
Why do home care settings lead the point-of-care glucose testing market?
Why are test strips the fastest-growing product type in the point-of-care glucose testing market?
What makes North America the leading point-of-care glucose testing market?
Why is Asia Pacific the fastest-growing region for point-of-care glucose testing?
Who holds a significant market share in the point-of-care glucose testing landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization